Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
PDB: 82 results

5KX7
DownloadVisualize
BU of 5kx7 by Molmil
Irak4-inhibitor co-structure
Descriptor: Interleukin-1 receptor-associated kinase 4, ~{N}-(3-aminocarbonyl-1-methyl-pyrazol-4-yl)-6-(1-methylpyrazol-4-yl)pyridine-2-carboxamide
Authors:Fischmann, T.O.
Deposit date:2016-07-20
Release date:2016-08-17
Last modified:2016-08-24
Method:X-RAY DIFFRACTION (2.8 Å)
Cite:Efforts towards the optimization of a bi-aryl class of potent IRAK4 inhibitors.
Bioorg.Med.Chem.Lett., 26, 2016
4U9A
DownloadVisualize
BU of 4u9a by Molmil
Sulphur Anomalous Crystal Structure of Asymmetric IRAK4 Dimer
Descriptor: Interleukin-1 receptor-associated kinase 4, STAUROSPORINE, SULFATE ION
Authors:Ferrao, R, Liu, Q, Wu, H.
Deposit date:2014-08-05
Release date:2014-09-24
Last modified:2023-12-27
Method:X-RAY DIFFRACTION (2.8 Å)
Cite:IRAK4 Dimerization and trans-Autophosphorylation Are Induced by Myddosome Assembly.
Mol.Cell, 55, 2014
5W84
DownloadVisualize
BU of 5w84 by Molmil
CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 4)
Descriptor: 4-(benzylamino)-6-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]pyridine-3-carboxamide, Interleukin-1 receptor-associated kinase 4
Authors:Sack, J.S.
Deposit date:2017-06-21
Release date:2017-10-11
Last modified:2017-10-25
Method:X-RAY DIFFRACTION (2.9 Å)
Cite:Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors.
Bioorg. Med. Chem. Lett., 27, 2017
8V1O
DownloadVisualize
BU of 8v1o by Molmil
Crystal structure of IRAK4 kinase domain with compound 4
Descriptor: CHLORIDE ION, GLYCEROL, Interleukin-1 receptor-associated kinase 4, ...
Authors:Weiss, M.M, Zheng, X, Browne, C.M, Campbell, V, Chen, D, Enerson, B, Fei, X, Huang, X, Klaus, C.R, Li, H, Mayo, M, McDonald, A.A, Paul, A, Sharma, K, Shi, Y, Slavin, A, Walter, D.M, Yuan, K, Zhang, Y, Zhu, X, Kelleher, J, Ji, N, Walker, D, Mainolfi, N.
Deposit date:2023-11-21
Release date:2024-07-03
Last modified:2024-07-24
Method:X-RAY DIFFRACTION (2.92 Å)
Cite:Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma.
J.Med.Chem., 67, 2024
7QG2
DownloadVisualize
BU of 7qg2 by Molmil
IRAK4 in complex with inhibitor
Descriptor: 6-methyl-4-[(1-methylcyclopropyl)amino]-2-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]pyrido[4,3-d]pyrimidin-5-one, Interleukin-1 receptor-associated kinase 4
Authors:Xue, Y, Aagaard, A, Robb, G.R, Degorce, S.L.
Deposit date:2021-12-07
Release date:2022-05-04
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (3.031 Å)
Cite:Identification and optimisation of a pyrimidopyridone series of IRAK4 inhibitors.
Bioorg.Med.Chem., 63, 2022
7C2W
DownloadVisualize
BU of 7c2w by Molmil
Crystal Structure of IRAK4 kinase in complex with a small molecule inhibitor
Descriptor: Interleukin-1 receptor-associated kinase 4, N-(2-morpholin-4-yl-1,3-benzoxazol-6-yl)-6-pyridin-4-yl-pyridine-2-carboxamide
Authors:Krishnamurthy, N.R, Anirudha, L.
Deposit date:2020-05-09
Release date:2020-11-25
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (3.2 Å)
Cite:Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies.
Acs Med.Chem.Lett., 11, 2020
3MOP
DownloadVisualize
BU of 3mop by Molmil
The ternary Death Domain complex of MyD88, IRAK4, and IRAK2
Descriptor: Interleukin-1 receptor-associated kinase 4, Interleukin-1 receptor-associated kinase-like 2, Myeloid differentiation primary response protein MyD88
Authors:Lin, S.-C, Lo, Y.-C, Wu, H.
Deposit date:2010-04-23
Release date:2010-06-02
Last modified:2024-02-21
Method:X-RAY DIFFRACTION (3.4 Å)
Cite:Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling.
Nature, 465, 2010
<1234

 

222926

PDB entries from 2024-07-24

PDB statisticsPDBj update infoContact PDBjnumon